« Osteoporosis drugs may reduce breast cancer risk | Home | Medication adherence poor in COPD patients »
Hydroxychloroquine May Help Delay Skin Damage In SLE Patients.
By jeremyc | March 3, 2010
MedPage Today (3/2, Walsh) reported that, according to a study published in March issue of Arthritis Care & Research, “treatment with hydroxychloroquine (Plaquenil) may help delay the occurrence of skin damage in patients with systemic lupus erythematosus (SLE).” In a study of “580 patients who had not yet developed skin damage at baseline,” researchers found that use of hydroxychloroquine “was associated with a longer time until integument damage — defined as scarring alopecia, extensive skin scarring, and skin ulcers — was present.” Moreover, “the cumulative probability of damage at five years was 5% for those taking hydroxychloroquine, compared with 24% for those who were not on the drug.”
Topics: | Uncategorized |
Comments are closed.
